Results 1 to 10 of about 1,505,633 (297)

Antinuclear antibodies in COVID 19

open access: yesClinical and Translational Science, 2021
We appreciated very much the interesting study by Chang et al.1 on the presence of antinuclear antibodies (ANAs) in patients with moderate/critical coronavirus disease 2019 (COVID 19).
Paolo Muratori   +3 more
doaj   +2 more sources

The Past, Present, and Future in Antinuclear Antibodies (ANA)

open access: yesDiagnostics, 2022
Autoantibodies are a hallmark of autoimmunity and, specifically, antinuclear antibodies (ANAs) are the most relevant autoantibodies present in systemic autoimmune rheumatic diseases (SARDs).
Juan Irure-Ventura, Marcos López-Hoyos
doaj   +2 more sources

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

open access: yesPLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy   +8 more
doaj   +2 more sources

Intracellular and circulating neuronal antinuclear antibodies in human epilepsy

open access: yesNeurobiology of Disease, 2013
There are overwhelming data supporting the inflammatory origin of some epilepsies (e.g., Rasmussen's encephalitis and limbic encephalitis). Inflammatory epilepsies with an autoimmune component are characterized by autoantibodies against membrane-bound ...
Philip H. Iffland, II   +8 more
doaj   +2 more sources

Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis

open access: yesBiomedicines, 2022
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by the presence of antimitochondrial and antinuclear antibodies in patients’ serum.
Alicja Bauer   +2 more
doaj   +1 more source

Increasing Prevalence of Antinuclear Antibodies in the United States

open access: yesArthritis & Rheumatology, 2022
Growing evidence suggests increasing frequencies of autoimmunity and autoimmune diseases, but findings are limited by the lack of systematic data and evolving approaches and definitions.
G. Dinse   +7 more
semanticscholar   +1 more source

Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?

open access: yesFrontiers in Immunology, 2022
Systemic sclerosis (SSc) is a connective tissue disease characterized by extensive fibrosis of the skin and internal organs, associated with vasculopathy and autoimmune features.
Aurélien Chepy   +5 more
semanticscholar   +1 more source

Antimitochindrial and antinuclear antibodies in primary biliary cholangitis [PDF]

open access: yesĶazaķstannyṇ Klinikalyķ Medicinasy, 2019
In this work we reviewed the key antimitochondrial and antinuclear antibodies in primary biliary cholangitis – an autoimmune cholestatic disorder with destruction of intralobular biliary ductules.
Dana Saipiyeva   +6 more
doaj   +1 more source

A study of clinical manifestations and their association with antinuclear antibodies in various autoimmune connective tissue disorders

open access: yesIndian Journal of Dermatology, 2023
Background: Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal ...
Rupa D Kondeti   +5 more
doaj   +1 more source

Can Antinuclear Antibodies (ANA) be Monoclonal?

open access: yesCase Reports in Nephrology, 2021
Background. Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal ...
Laura Biederman   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy